Edwards Lifesciences (EW) News Today $69.86 +0.46 (+0.66%) Closing price 04/14/2025 03:58 PM EasternExtended Trading$69.25 -0.61 (-0.87%) As of 08:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Fmr LLC Has $179.80 Million Stock Position in Edwards Lifesciences Co. (NYSE:EW)Fmr LLC grew its position in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 31.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,428,743 shares of the medical research company's stock after buying an addApril 15 at 4:50 AM | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Position Reduced by Envestnet Asset Management Inc.Envestnet Asset Management Inc. reduced its position in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 18.5% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 408,835 shares of the medical research company'sApril 15 at 4:40 AM | marketbeat.comEdwards Lifesciences receives CE Mark for Sapien M3April 14 at 11:34 PM | markets.businessinsider.comBalanced Outlook on Edwards Lifesciences Amid TMTT Growth and TAVR Market ChallengesApril 14 at 4:06 PM | tipranks.comEdwards Lifesciences (EW) Secures CE Mark for Innovative Mitral Valve System | EW Stock NewsApril 14 at 9:37 AM | gurufocus.comEdwards SAPIEN M3 Receives CE Mark, Becoming World's First Transfemoral Transcatheter Mitral ...April 14 at 9:37 AM | gurufocus.com6,455 Shares in Edwards Lifesciences Co. (NYSE:EW) Purchased by Crux Wealth AdvisorsCrux Wealth Advisors purchased a new stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 6,455 shares of the medical research company's stock, valued at approximately $478,April 14 at 7:37 AM | marketbeat.comAdvisory Services Network LLC Raises Holdings in Edwards Lifesciences Co. (NYSE:EW)Advisory Services Network LLC increased its stake in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 69.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 27,429 shares of the medical reseApril 14 at 5:22 AM | marketbeat.comEdwards Lifesciences (EW) -- Expanding TAVR Market Amidst Clinical Advancements | Wedgewood ...April 13 at 6:19 PM | gurufocus.comEdwards Lifesciences (EW) -- Expanding TAVR Market Amidst Clinical Advancements | Wedgewood ...April 13 at 5:55 PM | gurufocus.comTruist Financial Issues Pessimistic Forecast for Edwards Lifesciences (NYSE:EW) Stock PriceTruist Financial lowered their price objective on Edwards Lifesciences from $78.00 to $75.00 and set a "hold" rating on the stock in a report on Friday.April 13 at 9:38 AM | marketbeat.comTreasurer of the State of North Carolina Acquires 16,280 Shares of Edwards Lifesciences Co. (NYSE:EW)Treasurer of the State of North Carolina raised its stake in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 5.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 324,376 shares of the medApril 13 at 6:46 AM | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Shares Sold by Phoenix Financial Ltd.Phoenix Financial Ltd. lessened its holdings in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 9.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 44,309 shares of the medical rApril 13 at 6:17 AM | marketbeat.comRenaissance Technologies LLC Sells 569,207 Shares of Edwards Lifesciences Co. (NYSE:EW)Renaissance Technologies LLC decreased its stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 46.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 652,493 shares of the medical research company'sApril 13 at 5:55 AM | marketbeat.comBank of Nova Scotia Acquires 36,345 Shares of Edwards Lifesciences Co. (NYSE:EW)Bank of Nova Scotia increased its stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 20.2% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 216,604 shares of the medical research company's stock after buying an additApril 13 at 5:42 AM | marketbeat.comCerity Partners LLC Purchases 4,012 Shares of Edwards Lifesciences Co. (NYSE:EW)Cerity Partners LLC increased its holdings in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 3.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 126,834 shares of the medical research company's stock after purchApril 13 at 5:25 AM | marketbeat.comKennedy Capital Management LLC Increases Stock Position in Edwards Lifesciences Co. (NYSE:EW)Kennedy Capital Management LLC raised its stake in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 25.8% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 192,518 shares of the medical research company's stock after purchasing an additionalApril 12 at 8:59 AM | marketbeat.comInvesco Ltd. Has $309.48 Million Holdings in Edwards Lifesciences Co. (NYSE:EW)Invesco Ltd. raised its holdings in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 30.7% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 4,180,471 shares of the medical research company's stock after buying an additional 982,170 shareApril 12 at 5:54 AM | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Shares Sold by Bank of Montreal CanBank of Montreal Can cut its position in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 22.3% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 917,870 shares of the medical research company's stock after selling 263,114 shares during the periApril 12 at 5:48 AM | marketbeat.comMaxwell Wealth Strategies Inc. Cuts Stock Position in Edwards Lifesciences Co. (NYSE:EW)Maxwell Wealth Strategies Inc. trimmed its position in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 42.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 15,293 shares of the medical researchApril 11, 2025 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Shares Purchased by APG Asset Management N.V.APG Asset Management N.V. boosted its stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 261.1% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 424,027 shares of the medical research company's stock after purchasing an additional 306,596 shares duringApril 11, 2025 | marketbeat.comLegal & General Group Plc Has $312.43 Million Holdings in Edwards Lifesciences Co. (NYSE:EW)Legal & General Group Plc trimmed its stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 21.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,220,318 shares of the medical research company's stock after sApril 11, 2025 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Shares Purchased by Wells Fargo & Company MNWells Fargo & Company MN boosted its position in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 10.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 844,023 shares of the medical research compaApril 11, 2025 | marketbeat.comArrowstreet Capital Limited Partnership Decreases Position in Edwards Lifesciences Co. (NYSE:EW)Arrowstreet Capital Limited Partnership decreased its position in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 48.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 45,988 shares of theApril 11, 2025 | marketbeat.comInsider Selling: Edwards Lifesciences Co. (NYSE:EW) VP Sells 300 Shares of StockEdwards Lifesciences Co. (NYSE:EW - Get Free Report) VP Daniel J. Lippis sold 300 shares of Edwards Lifesciences stock in a transaction dated Tuesday, April 8th. The shares were sold at an average price of $70.61, for a total value of $21,183.00. Following the transaction, the vice president now owns 22,863 shares in the company, valued at $1,614,356.43. This trade represents a 1.30 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.April 10, 2025 | marketbeat.comApplied Finance Capital Management LLC Increases Stock Position in Edwards Lifesciences Co. (NYSE:EW)Applied Finance Capital Management LLC raised its stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 69.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,305 shares of the medical resApril 10, 2025 | marketbeat.comRathbones Group PLC Purchases 15,192 Shares of Edwards Lifesciences Co. (NYSE:EW)Rathbones Group PLC lifted its position in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 1.2% in the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,299,171 shares of the medical research company's stock after acquiring an additional 15,1April 9, 2025 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Shares Sold by Bell Asset Management LtdBell Asset Management Ltd lowered its holdings in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 44.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 54,132 shares of the medical research comApril 9, 2025 | marketbeat.comAster Capital Management DIFC Ltd Raises Holdings in Edwards Lifesciences Co. (NYSE:EW)Aster Capital Management DIFC Ltd lifted its stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 816.4% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 8,642 shares of the medical research company's stock after purchasinApril 9, 2025 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Shares Sold by Sit Investment Associates Inc.Sit Investment Associates Inc. trimmed its holdings in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 50.2% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 5,850 shares of the medical research company's stock after seApril 9, 2025 | marketbeat.com30,428 Shares in Edwards Lifesciences Co. (NYSE:EW) Acquired by ExodusPoint Capital Management LPExodusPoint Capital Management LP purchased a new stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 30,428 shares of the medical research company's stock, valued at approximatelyApril 9, 2025 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Shares Sold by 2Xideas AG2Xideas AG lowered its stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 20.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 177,296 shares of the medical research company's stock after sellinApril 8, 2025 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Shares Sold by Peapack Gladstone Financial CorpPeapack Gladstone Financial Corp trimmed its stake in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 1.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 288,450 shares of the medical researApril 8, 2025 | marketbeat.comIlmarinen Mutual Pension Insurance Co Has $4.89 Million Stock Position in Edwards Lifesciences Co. (NYSE:EW)Ilmarinen Mutual Pension Insurance Co boosted its stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 40.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 66,000 shares of the medical research company'sApril 8, 2025 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Position Boosted by Russell Investments Group Ltd.Russell Investments Group Ltd. boosted its position in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 20.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,522,015 shares of the medical research comApril 8, 2025 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Shares Bought by Aviva PLCAviva PLC grew its holdings in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 2.6% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 797,915 shares of the medical research company's stock after buying an additional 20,0April 8, 2025 | marketbeat.comResona Asset Management Co. Ltd. Acquires Shares of 185,539 Edwards Lifesciences Co. (NYSE:EW)Resona Asset Management Co. Ltd. acquired a new position in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 185,539 shares of the medical research company's sApril 8, 2025 | marketbeat.comPitcairn Co. Cuts Stock Holdings in Edwards Lifesciences Co. (NYSE:EW)Pitcairn Co. lowered its position in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 33.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 15,025 shares of the medical research company's stock afterApril 7, 2025 | marketbeat.comWorld Investment Advisors Has $5.08 Million Holdings in Edwards Lifesciences Co. (NYSE:EW)World Investment Advisors decreased its stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 5.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 68,548 shares of the medical reseApril 6, 2025 | marketbeat.comNational Bank of Canada FI Boosts Stake in Edwards Lifesciences Co. (NYSE:EW)National Bank of Canada FI grew its position in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 9.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 332,387 shares of the medical research comApril 6, 2025 | marketbeat.comSchroder Investment Management Group Takes Position in Edwards Lifesciences Co. (NYSE:EW)Schroder Investment Management Group bought a new position in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 96,655 shares of the medical resApril 6, 2025 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Shares Sold by Huntington National BankHuntington National Bank lowered its stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 11.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 194,928 shares of the medical research company's stock after sellingApril 5, 2025 | marketbeat.comFranklin Resources Inc. Reduces Stake in Edwards Lifesciences Co. (NYSE:EW)Franklin Resources Inc. reduced its holdings in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 3.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,151,709 shares of the medical research compaApril 5, 2025 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Position Decreased by Orion Portfolio Solutions LLCOrion Portfolio Solutions LLC reduced its holdings in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 29.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 21,558 shares of the medical research cApril 5, 2025 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Position Increased by Cinctive Capital Management LPCinctive Capital Management LP raised its position in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 166.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 148,923 shares of the medicalApril 4, 2025 | marketbeat.comGroupama Asset Managment Cuts Stock Position in Edwards Lifesciences Co. (NYSE:EW)Groupama Asset Managment trimmed its holdings in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 18.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 27,809 shares of the medical research company'sApril 4, 2025 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Shares Purchased by Geode Capital Management LLCGeode Capital Management LLC grew its position in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 0.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 13,647,341 shares of the medical research company's stocApril 4, 2025 | marketbeat.comAlliancebernstein L.P. Reduces Stock Holdings in Edwards Lifesciences Co. (NYSE:EW)Alliancebernstein L.P. reduced its stake in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 70.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,038,677 shares of the medical research compApril 3, 2025 | marketbeat.comCalifornia Public Employees Retirement System Sells 288,681 Shares of Edwards Lifesciences Co. (NYSE:EW)California Public Employees Retirement System lessened its stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 26.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 787,027 shares of the medical reseaApril 3, 2025 | marketbeat.comB. Metzler seel. Sohn & Co. AG Has $4.71 Million Position in Edwards Lifesciences Co. (NYSE:EW)B. Metzler seel. Sohn & Co. AG trimmed its stake in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 20.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 63,646 shares of theApril 2, 2025 | marketbeat.com Remove Ads Get Edwards Lifesciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EW and its competitors with MarketBeat's FREE daily newsletter. Email Address EW Media Mentions By Week EW Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EW News Sentiment▼1.320.80▲Average Medical News Sentiment EW News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EW Articles This Week▼3623▲EW Articles Average Week Remove Ads Get Edwards Lifesciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EW and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Boston Scientific News Stryker News Medtronic News Becton, Dickinson and Company News ResMed News IDEXX Laboratories News DexCom News STERIS News Insulet News Baxter International News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:EW) was last updated on 4/15/2025 by MarketBeat.com Staff From Our PartnersGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edwards Lifesciences Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Edwards Lifesciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.